Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study on safety of weekly liposomal amphotericin B (AmBisome) for antifungal primary prophylaxis
2005-004495-21Phase 2Terminated
- Sponsor
- Gilead Sciences
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of amphotericin b in invasive mycoses, sponsored by Gilead Sciences. Primary endpoint: Safety profile of prophylactic liposomal amphotericin B. Started Sep 2006; status: terminated.
02
Drugs
amphotericin b
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2005-004495-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004495-21.